Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00141154 | Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan | PHASE3 | COMPLETED | 1,234 | — | — | Oct 1, 2004 | - | Mar 3, 2021 | 38 | Japan |
| Name | Type | Description |
|---|---|---|
| Celecoxib | DRUG | - |
| Placebo | DRUG | - |
| Loxoprofen | DRUG | - |
Inclusion Criteria: * Patients who have the major site of the low back pain at the 12th thoracic vertebra or lower * Patients who have had low back pain for at least two weeks Exclusion Criteria: * Patients who have a previous history or complication of rheumatoid arthritis, spondylarthrosis with...